ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $122,000 | -29.5% | 21,000 | 0.0% | 0.05% | -26.4% |
Q2 2015 | $173,000 | 0.0% | 21,000 | 0.0% | 0.07% | +2.9% |
Q1 2015 | $173,000 | +20.1% | 21,000 | 0.0% | 0.07% | +14.8% |
Q4 2014 | $144,000 | +48.5% | 21,000 | +16.7% | 0.06% | +38.6% |
Q3 2014 | $97,000 | – | 18,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |